The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
The opioid epidemic in the United States has "peaked," says Dr. Toby Cosgrove, one of the nation's leading voices on health-care reform.
"We're starting to see the understanding of the problem," Cosgrove said Monday on CNBC's "Squawk Box. " "[We] are getting to the point where people are certainty prescribing fewer drugs and people are recognizing how serious this is."
But Cosgrove, former CEO of the renowned Cleveland Clinic, also said opioids remain a major health risk for Americans, especially from drugs laced with synthetic opioids such as the pain killer fentanyl or ones with similar effects like carfentanil.
"Carfentanil is 10,000 times as potent as morphine. These drugs are getting laced," said Cosgrove, who is also a cardiac surgeon. "We just had an outbreak of deaths in Ohio from drugs being laced with very potent carfentanil and fentanyl."
Opioids — including heroin, a poppy seed derivative, and lab-made fentanyl — were involved in more than 42,000 overdose deaths in 2016, according to the Centers for Disease Control and Prevention.
The opioid epidemic affects American children as well.
The number of pediatric opioid hospitalizations requiring intensive care nearly doubled to 1,504 patients between 2012 and 2015, from 797 patients between 2004 and 2007, according to a study published by Pediatrics.
President Donald Trump has attacked drugmakers for their role in fueling the opioid epidemic and released a plan to reduce the number of opioid prescriptions in the U.S.
Google announced in July that Cosgrove would join the Google Cloud Healthcare and Life Sciences team as an executive advisor. He will assist in the Alphabet unit's goal of lowering costs health costs and improving patient experiences.
Cosgrove led the Cleveland Clinic for nearly 13 years before stepping down in May 2017.